Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura in southern Iran.

× No keyword cloud information.

9 in total

Review 1. Clinical practice. Thrombotic thrombocytopenic purpura.

Authors: James N George
Journal: N Engl J Med Date: 2006-05-04 Impact factor: 91.245

2. Clinical and laboratory patterns of the haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura in southern Iran.

Authors: Mehran Karimi; Ameneh Sabzi; Flora Peyvandi; Pier Mannuccio Mannucci
Journal: Intern Emerg Med Date: 2006 Impact factor: 3.397

3. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.

Authors: Jessica Caprioli; Marina Noris; Simona Brioschi; Gaia Pianetti; Federica Castelletti; Paola Bettinaglio; Caterina Mele; Elena Bresin; Linda Cassis; Sara Gamba; Francesca Porrati; Sara Bucchioni; Giuseppe Monteferrante; Celia J Fang; M K Liszewski; David Kavanagh; John P Atkinson; Giuseppe Remuzzi
Journal: Blood Date: 2006-04-18 Impact factor: 22.113

4. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

Authors: G A Rock; K H Shumak; N A Buskard; V S Blanchette; J G Kelton; R C Nair; R A Spasoff
Journal: N Engl J Med Date: 1991-08-08 Impact factor: 91.245

5. The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota.

Authors: D L Martin; K L MacDonald; K E White; J T Soler; M T Osterholm
Journal: N Engl J Med Date: 1990-10-25 Impact factor: 91.245

6. Population-based trends in pediatric hemolytic uremic syndrome in California, 1994-1999: substantial underreporting and public health implications.

Authors: Kate C Cummings; Janet C Mohle-Boetani; S Benson Werner; Duc J Vugia
Journal: Am J Epidemiol Date: 2002-05-15 Impact factor: 4.897

7. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.

Authors: D R Terrell; L A Williams; S K Vesely; B Lämmle; J A K Hovinga; J N George
Journal: J Thromb Haemost Date: 2005-07 Impact factor: 5.824

8. Increasing mortality from thrombotic thrombocytopenic purpura in the United States--analysis of national mortality data, 1968-1991.

Authors: T J Török; R C Holman; T L Chorba
Journal: Am J Hematol Date: 1995-10 Impact factor: 10.047

9. Incidence of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome.

Authors: David P Miller; James A Kaye; Kathleen Shea; Najat Ziyadeh; Clorinda Cali; Corri Black; Alexander M Walker
Journal: Epidemiology Date: 2004-03 Impact factor: 4.822

9 in total